Study results showed AbbVie's Kaletra did no better than standard treatment. Meanwhile, a generic version of Fujifilm's Avigan, which the NIH said it is considering, showed signs of efficacy, though some regulators are skeptical of the flu drug.
In a survey of 170 sites, Continuum Clinical found that around one-third of sites anticipate impacts on their ability to recruit and retain participants. The FDA guidance listed considerations patient protection and conduct of trials during the pandemic.
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Today is the final day to save $300 when you register for healthcare investment conference MedCity INVEST.
We’ve extended our early rate deal —you can save $300 on your ticket if you register by Tuesday March 10.
Time is running out to save on MedCity INVEST, the national conference highlighting investment trends in healthcare and spotlighting startups across health IT and life sciences.
One of the buyers, AstraZeneca, said separately that it would divest several hypertension drugs as it shifts the focus of its pipeline to newer medicines.
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.
Our national conference highlighting investment trends in healthcare and innovative startups across health IT and life sciences is happening April 21-22 in Chicago. You should be there.
Unlike most pitching events, the INVEST Pitch Perfect competition spans health IT and life science sectors, including biopharma, diagnostics, and medical devices.
At the Oliver Wyman Health Innovation Summit in Chicago, Josh Michelson, co-director of Oliver Wyman's Health Innovation Center charted a path forward to make real advancements in improving healthcare's Triple Aim.
Reuters reported that the drug, Rinvoq, will carry a list price of $59,000 per year. AbbVie's top-selling drug, Humira, is also approved for treating RA.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.
The companies said the acquisition would diversify AbbVie's portfolio. However, Allergan also faces headwinds from generic competition. A bid to stop a challenge to the patents on its second top-selling drug failed earlier this year.
The health system will offer NowPow's services to about 1,200 Medicaid patients who are part of Health Home, its care coordination program that provides medical, mental health, substance abuse, social and family support services.
The company creates video games for doctors that allow them to assist virtual patients in an effort to improve their clinical decision-making skills.
A new report finds that most emerging pharma companies aren't using advanced data analytics adequately and that may hamper their commercialization efforts and in retaining sales force.
In data at the ASCO meeting last week, Grail showed a 1 percent false-positive rate. While that number seems likely to go down, even such a low rate can make a significant difference for patients.